Literature DB >> 20139614

Development of a fucoidan-specific antibody and measurement of fucoidan in serum and urine by sandwich ELISA.

Yoshiharu Tokita1, Katsuyuki Nakajima, Hiroshi Mochida, Masahiko Iha, Takeaki Nagamine.   

Abstract

Fucoidan exhibits various biological properties. We raised a novel antibody against fucoidan extracted from Cladosiphon okamuranus and developed a sandwich ELISA method to measure fucoidan. The fucoidan antibody was specific and did not cross-react with other polysulfated polysaccharides. Fucoidan recovery from serum and urine by ELISA was 86-113%. Intra- and inter-assay CVs were 1.5-13.4%. Assay linearity was maintained after 3-fold dilution of each sample with phosphate-buffer saline (PBS). In the serum and urine of healthy volunteers (n=10), fucoidan was not detected before administration, and the levels markedly increased 6 and 9 h after oral administration. The molecular weight of the serum fucoidan determined by HPLC gel filtration remained unchanged, whereas that of urine fucoidan was significantly reduced. This is the first ELISA method of measuring serum and urine fucoidan levels after oral administration. The method is simple, reliable, and practical for the analysis of samples, especially urine samples.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20139614     DOI: 10.1271/bbb.90705

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  31 in total

1.  Activation of NK cells in male cancer survivors by fucoidan extracted from Cladosiphon okamuranus.

Authors:  Takeaki Nagamine; Kizuku Kadena; Makoto Tomori; Katsuyuki Nakajima; Masahiko Iha
Journal:  Mol Clin Oncol       Date:  2019-10-31

2.  Fucoidan extract induces apoptosis in MCF-7 cells via a mechanism involving the ROS-dependent JNK activation and mitochondria-mediated pathways.

Authors:  Zhongyuan Zhang; Kiichiro Teruya; Hiroshi Eto; Sanetaka Shirahata
Journal:  PLoS One       Date:  2011-11-11       Impact factor: 3.240

Review 3.  Therapies from fucoidan; multifunctional marine polymers.

Authors:  Janet Helen Fitton
Journal:  Mar Drugs       Date:  2011-09-30       Impact factor: 6.085

Review 4.  Fucoidan and cancer: a multifunctional molecule with anti-tumor potential.

Authors:  Farzaneh Atashrazm; Ray M Lowenthal; Gregory M Woods; Adele F Holloway; Joanne L Dickinson
Journal:  Mar Drugs       Date:  2015-04-14       Impact factor: 5.118

5.  Cytotoxic effects of fucoidan nanoparticles against osteosarcoma.

Authors:  Ryuichiro Kimura; Takayoshi Rokkaku; Shinji Takeda; Masachika Senba; Naoki Mori
Journal:  Mar Drugs       Date:  2013-10-30       Impact factor: 5.118

6.  Intestinal absorption of fucoidan extracted from the brown seaweed, Cladosiphon okamuranus.

Authors:  Takeaki Nagamine; Kyoumi Nakazato; Satoru Tomioka; Masahiko Iha; Katsuyuki Nakajima
Journal:  Mar Drugs       Date:  2014-12-25       Impact factor: 5.118

7.  Effects of fucoidan from Fucus vesiculosus in reducing symptoms of osteoarthritis: a randomized placebo-controlled trial.

Authors:  Stephen P Myers; Ann M Mulder; Don G Baker; Shelley R Robinson; Margaret I Rolfe; Lyndon Brooks; J Helen Fitton
Journal:  Biologics       Date:  2016-05-26

8.  Effects of Ingesting Fucoidan Derived from Cladosiphon okamuranus Tokida on Human NK Cells: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Pilot Study.

Authors:  Makoto Tomori; Takeaki Nagamine; Tomofumi Miyamoto; Masahiko Iha
Journal:  Mar Drugs       Date:  2021-06-15       Impact factor: 5.118

9.  Fucoidan extract enhances the anti-cancer activity of chemotherapeutic agents in MDA-MB-231 and MCF-7 breast cancer cells.

Authors:  Zhongyuan Zhang; Kiichiro Teruya; Toshihiro Yoshida; Hiroshi Eto; Sanetaka Shirahata
Journal:  Mar Drugs       Date:  2013-01-09       Impact factor: 5.118

Review 10.  Therapies from Fucoidan: An Update.

Authors:  Janet Helen Fitton; Damien N Stringer; Samuel S Karpiniec
Journal:  Mar Drugs       Date:  2015-09-16       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.